Bon Natural Life Limited bone Stocks are increasing on Friday after the company announced that it had signed a $ 12 million supply contract to jointly develop Apple Polyphenol injection health solutions.
Must know: BON won a long supply contract of 24 months and co -developed the aforementioned health solution. Shanghai Yun HongChina functional ingredient distributor.
Partnership will use Bon’s patented extraction technology to deliver a formulation that combines antioxidant apple polyphenol and vegetable protein.
“One of the world’s best Apple polyphenol suppliers, we dominate the niche market by utilizing the vertically integrated supply chain. Yongwei huChairman and CEO of Bon.
BON stocks were traded abnormally in large quantities and exchanged 270 million shares. According to the data of Benzinga Pro, the company’s 100 -day average is 15.27 million.
Reference: Is Chinese technology in ‘serious danger’ during the increase in trade wars? The analyst said that the symbol is rising in the retaliation option list.
Bon price action: At the time of writing, Bon shares make 55.1% higher transactions at 9 cents, depending on the data of Benzinga Pro.
Image: This picture was created using artificial intelligence through Midjourney.
Market news and data provided by Benzinga APIS
© 2025 benzinga.com. Benzinga does not provide investment advice. All rights holdings.
